„Aktuelle Entwicklungen im Europäischen Kartellrecht”
Isabel Oest speaks on recent developments in European Antitrust
Regionalveranstaltung der Studienvereinigung Kartellrecht – 26 October 2021, Frankfurt am Main
Dr. Dominique Wagener speaks on „Stand der Reformvorschläge der Kommission zur Vertikal-GVO und den Vertikalen Leitlinien”
Compliance – worth it after all!
Consideration of pre-infringement compliance when calculating antitrust fines
Relative Market Power – What you need to know
The latest German competition law amendment reforms the prohibition rules for undertakings with relative or superior market power. While the changes aim to meet new challenges in the digital economy, they have significant consequences across industries
Who‘s Who Legal Competition EMEA/Future Leaders 2021
COMMEO achieves notable group success in the two current Who’s Who Legal rankings. In addition to the law firm being listed among the top 8 “Leading Firms” for EMEA, Stephanie Pautke and Johanna Kübler are recognized as “Global Elite Thought Leaders”. Dominique Wagener stands out for her “incisive handling of contentious e-commerce competition matters” and Jörg-Martin Schultze is appreciated as “very experienced and great to work with”. Isabel Oest is recognized as the only EMEA partner listed for Germany alongside seven international colleagues as “Most Highly Regarded”.
2020 in review: business as usual despite Corona?
An overview of the activities and most important proceedings of the German Federal Cartel Office and the European Commission in the past year
Handelsblatt/Best Lawyers 2021
All five partners of COMMEO among “Germany’s Best Lawyers 2021” for competition law in Germany. Congratulations to Isabel Oest who is listed for the first time in the year she became a partner.
WirtschaftsWoche 2021
“TOP Law Firm” and “TOP Lawyer”:
German business magazine WirtschaftsWoche ranks COMMEO as well as our four founding partners Jörg-Martin Schultze, Dominique Wagener, Stephanie Pautke and Johanna Kübler in the field of competition law in Germany.
Pharmaceutical companies: beware of excessive pricing
Competition authorities both at an EU as well as at a national level continue to keep a keen eye on pursuing excessive pricing cases against pharmaceutical companies
Rail track cartel VI: The lump-sum damages booster
The Federal Court of Justice further backs claimants in follow-on damages litigation in ruling on contractual lump-sum clauses for cartel damages in supply agreements applying antitrust-specific standards for the assessment of such clauses